Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2019-06-01
2022-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is Life Worth Living After Major Emergency GI Surgery? Patient Reported Outcome in Elderly Emergency Surgery Patients
NCT02377687
Prediction of Abdominal Complications After GastroEnterological Surgery
NCT03828266
Determining Universal Processes Related to Best Outcome in Emergency Gastrointestinal Surgery: an International Evaluation
NCT02179112
Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage
NCT05250882
Best Management of Sigmoid Volvulus: A Prospective Randomized Trial
NCT01682395
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
CHARACTERISTICS OF THE STUDY POPULATION
1. Target Population The target population will be all patients between the ages of 18-99, regardless of sex, racial or ethnic background that underwent emergent laparotomy and planned/unplanned re-laparotomy. Variables to be analyzed in the study are in the attached data collection excel sheet.
2. Key Inclusion Criteria
* All adult patients ages 18-99, regardless of sex, racial or ethnic background who will undergo or underwent emergency abdominal surgery for acute abdomen due to perforated viscus, acute bowel obstruction, bowel ischemia, acute or gangrenous gall bladder, post-operative complications such as anastomotic leaks after bowel anastomosis, abdominal compartment syndrome,enterocutaneous/enteroatmospheric fistula or bleeding.
* Investigators will also include patients after organ transplant that will undergo emergent surgery for post-operative bleeding, anastomotic leak or organ ischemia.
* As well as any patients undergoing bariatric surgery or colorectal procedures that develop any complication that might need return to the operating room emergently will also be included in the study from 2019 at Westchester Medical Center.
3. Key Exclusion Criteria
* Elective delayed repair for surgery done after clinic follow-up.
* Age \< 18 years or greater than 89 years of age
4. Vulnerable Populations Vulnerable populations such as children, fetuses, neonates, or prisoners will not be included in this research study.
5. Study Design This study is a prospective observational study of patients that are admitted to Westchester Medical Center and undergo emergency general surgery. Each chart will be reviewed for pre-op, intra-op, and post-op variables outlined in data collection tool. Data will be collected until one year after discharge on follow up visits. At the end of the study, all of this data will be analyzed to determine if there are any trends in mortality or morbidity for these patients. The variables will then be compared by using step-wise logistic regression techniques.
6. Study Duration The study will take place between 02/10/2019 to 1/31/2022.
7. Number of Subjects The study team/Investigators aim to enroll approximately 300 subjects.
Follow up:
Study team will follow patients for 1 year after discharge and the follow up visits are conducted in the clinic after 30 days, 3 months, 6 months and 1 year of discharge. Investigators will examine incision sites, drains if present and enquire about adequacy of pain control and unplanned readmission including any therapeutic or diagnostic procedures done, number of hospital days during readmission.
Statistical Analysis Chi-square difference tests will be used to assess significant differences in predictors on categorical outcomes. T-tests will be used to assess mean differences in predictors on continuous outcomes. Univariable and multivariable logistic regression analyses will be conducted for outcomes such as all-cause mortality, pneumonia, sepsis, and multi-organ failure. Univariable and multivariable linear regression will be performed for hospital length of stay.
Confidentiality Subjects will be recruited, consented, and data from medical record data will be gathered prospectively. Data will be obtained on a patient's pre and perioperative details, their interventions, and final outcomes. Two data files will be maintained: a master file and an analysis (de-identified data) file.
1. Master File: Identifiable Data: Medical Record Numbers, date of birth, admission date, discharge date, ICU admission date and time, any readmission data collected during follow-up, and date of death (if applicable) will be collected as part of this study and stored electronically in an Excel file (Master List). Each subject will be assigned an ID ( 3 digit number) under which all the collected information will be stored for that subject. This file will be password-protected. The Master File will also contain a unique id that is used to link identifiable data with the de-identified dataset used for analysis.
2. The de-identified dataset will also be password protected and each record will be organized by the unique ID. This file will include derived fields such as length of stay that will be calculated using data stored in the Master File.
RISK/BENEFIT ASSESSMENT
1. Potential Study Risks This study involves no more than minimal risk to subjects as it involves no additional treatment/interventions. There is the potential risk for breach of confidentiality. However, all research personnel will be trained in how to maintain confidentiality and protect PHI. Only research staff will have access to the de-identified information. Hard copies are locked in a file cabinet and electronic files are saved in password protected computers issued by WMC and computer access will be monitored.
2. Potential Study Benefits There are no direct benefits to the subjects participating in this study. Future patients may benefit from the information obtained from this prospective observational study. For example, to date, no large-scale prospective study on damage control surgery in trauma and non-traumatic pathology has been identified. If investigators observe an association between the variable that affects morbidity or mortality, investigators may be able to initiate appropriate therapy in a more timely fashion for future patients.
3. Data and Safety Monitoring Data Safety and monitoring will be done by the Principal Investigator and the research team. Data will be queried from the database and kept in a password protected excel spreadsheet. Only the PI will have the access to the data which has been coded with the subject identifier. The PI designated research team members will have the access to the de-identified data. Data will be stored on secure password protected Westchester Medical Center (WMC) servers. The only hard copies of patient documents will be the consent forms and HIPAA forms, which will be stored in a study binder that will be kept in locked cabinets in the PI's office. The identifiable PHI will be destroyed as soon as the data analysis is complete. The de-identified PHI will be kept in a database for future research. The hard copies of the study documents will be shredded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emergency Abdominal surgery
Emergency Abdominal surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Investigators will also include patients after organ transplant that will undergo emergent surgery for post-operative bleeding, anastomotic leak or organ ischemia.
* As well as any patients undergoing bariatric surgery or colorectal procedures that develop any complication that might need return to the operating room emergently will also be included in the study from 2019 at Westchester Medical Center.
Exclusion Criteria
* Age \< 18 years or greater than 89 years of age
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rifat Latifi
Chairman, Department of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rifat Latifi, MD
Role: PRINCIPAL_INVESTIGATOR
Chairman, Department of Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Westchester Medical Center
Valhalla, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12811
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.